62
Participants
Start Date
March 31, 2010
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
Pregabalin
FDA approved medication (capsules) at 75 mg and 200 mg doses
Placebo
Placebo capsules
Bowel preparation
Polyethylene glycol electrolyte solution bowel preparation
Mayo Clinic, Rochester
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
National Center for Research Resources (NCRR)
NIH
Mayo Clinic
OTHER